Alpha-2-delta subunit of voltage-gated calcium channel (α2δ subunit (or alpha2delta subunit))

The alpha‑2‑delta subunit is an auxiliary protein component found in complexes with voltage-gated calcium channels (VGCCs). It does not form the ion-conducting pore itself but modulates both the trafficking to the plasma membrane and functional properties—such as gating kinetics—of high-voltage activated VGCCs. The presence of this subunit increases surface density and alters activation thresholds so that physiological Ca^2+ influx occurs more efficiently during depolarization events. There are several isoforms encoded by different genes (e.g., CACNA2D1 encodes alpha‑2‑delta‑1), each with tissue-specific expression patterns. Alpha‑2‑delta is a validated therapeutic target for neuropathic pain and epilepsy because drugs like gabapentin or pregabalin bind specifically to this site on VGCCs. By doing so, they reduce abnormal neuronal excitability associated with these conditions without directly blocking ion flow through the main pore-forming α1-subunits. Mutations or altered expression levels in these auxiliary proteins have been linked to neurological diseases including ataxia, epilepsy, neuropathic pain syndromes, making them important both as drug targets and contributors to disease pathophysiology

Other names

Alpha-2-delta auxiliary subunitα2δ subunitCACNA2D (gene family encoding these proteins)Alpha2delta-1, alpha2delta-2, etc. (for specific isoforms)

Drugs such as gabapentin and pregabalin bind to the alpha‑2‑delta subunits, inhibiting their function. This reduces the trafficking/density or activity of high-voltage activated calcium channels at the cell surface, leading to decreased neurotransmitter release and reduced neuronal excitability—key for analgesic and anticonvulsant effects